Colgate-Palmolive (CL) — insider trading
Consumer Staples · NYSE
Colgate-Palmolive (CL) has 75 reported SEC Form 4 insider transactions in our data, including 6 open-market sales among the most recent 75 (latest 2026-10-01).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | NORRINGTON LORRIE M | Director | Grant / award / vesting | 300 | $87.42 | $26.2K | Form 4 |
| 2026-10-01 | Newman Brian | Director | Grant / award / vesting | 214 | $87.42 | $18.7K | Form 4 |
| 2026-10-01 | BILBREY JOHN P | Director | Grant / award / vesting | 271 | $87.42 | $23.7K | Form 4 |
| 2026-09-16 | Wallace Noel R. | Director, Officer (Chairman, President & CEO) | Grant / award / vesting (derivative) | 205,197 | — | $0 | Form 4 |
| 2026-09-16 | Wallace Noel R. | Director, Officer (Chairman, President & CEO) | Grant / award / vesting | 29,649 | — | $0 | Form 4 |
| 2026-09-16 | GRANT SHANE | Officer (COO, Americas) | Grant / award / vesting (derivative) | 50,902 | — | $0 | Form 4 |
| 2026-09-16 | GRANT SHANE | Officer (COO, Americas) | Grant / award / vesting | 7,355 | — | $0 | Form 4 |
| 2026-09-16 | Tsourapas Panagiotis | Officer (COO, CD, EMEA, APac, Skin) | Grant / award / vesting (derivative) | 31,814 | — | $0 | Form 4 |
| 2026-09-16 | Tsourapas Panagiotis | Officer (COO, CD, EMEA, APac, Skin) | Grant / award / vesting | 4,597 | — | $0 | Form 4 |
| 2026-09-16 | SUTULA STANLEY J III | Officer (Chief Financial Officer) | Grant / award / vesting (derivative) | 55,674 | — | $0 | Form 4 |
| 2026-09-16 | SUTULA STANLEY J III | Officer (Chief Financial Officer) | Grant / award / vesting | 8,045 | — | $0 | Form 4 |
| 2026-09-16 | Hazlin John | Officer (Chief Growth Officer) | Grant / award / vesting (derivative) | 27,042 | — | $0 | Form 4 |
| 2026-09-16 | Hazlin John | Officer (Chief Growth Officer) | Grant / award / vesting | 3,908 | — | $0 | Form 4 |
| 2026-09-16 | Massey Sally | Officer (Chief People Officer) | Grant / award / vesting (derivative) | 23,065 | — | $0 | Form 4 |
| 2026-09-16 | Massey Sally | Officer (Chief People Officer) | Grant / award / vesting | 3,333 | — | $0 | Form 4 |
| 2026-09-16 | Fishbone Betsy | Officer (CLO and Secretary) | Grant / award / vesting (derivative) | 15,271 | — | $0 | Form 4 |
| 2026-09-16 | Fishbone Betsy | Officer (CLO and Secretary) | Grant / award / vesting | 2,207 | — | $0 | Form 4 |
| 2026-09-16 | Malcolm Gregory | Officer (EVP and Controller) | Grant / award / vesting (derivative) | 7,477 | — | $0 | Form 4 |
| 2026-09-16 | Malcolm Gregory | Officer (EVP and Controller) | Grant / award / vesting | 1,081 | — | $0 | Form 4 |
| 2026-09-13 | Fishbone Betsy | Officer (CLO and Secretary) | Shares withheld for taxes / exercise cost | 472 | $86.80 | $41.0K | Form 4 |
| 2026-09-13 | Hazlin John | Officer (Chief Growth Officer) | Shares withheld for taxes / exercise cost | 499 | $86.80 | $43.3K | Form 4 |
| 2026-09-13 | Malcolm Gregory | Officer (EVP and Controller) | Shares withheld for taxes / exercise cost | 225 | $86.80 | $19.5K | Form 4 |
| 2026-09-13 | Massey Sally | Officer (Chief People Officer) | Shares withheld for taxes / exercise cost | 686 | $86.80 | $59.5K | Form 4 |
| 2026-09-13 | SUTULA STANLEY J III | Officer (Chief Financial Officer) | Shares withheld for taxes / exercise cost | 1,385 | $86.80 | $120.2K | Form 4 |
| 2026-09-13 | Tsourapas Panagiotis | Officer (COO, CD, EMEA, APac, Skin) | Shares withheld for taxes / exercise cost | 922 | $86.80 | $80.0K | Form 4 |
| 2026-09-13 | Wallace Noel R. | Director, Officer (Chairman, President & CEO) | Shares withheld for taxes / exercise cost | 4,892 | $86.80 | $424.6K | Form 4 |
| 2026-09-12 | Fishbone Betsy | Officer (CLO and Secretary) | Shares withheld for taxes / exercise cost | 331 | $86.80 | $28.7K | Form 4 |
| 2026-09-12 | Hazlin John | Officer (Chief Growth Officer) | Shares withheld for taxes / exercise cost | 439 | $86.80 | $38.1K | Form 4 |
| 2026-09-12 | Malcolm Gregory | Officer (EVP and Controller) | Shares withheld for taxes / exercise cost | 151 | $86.80 | $13.1K | Form 4 |
| 2026-09-12 | Massey Sally | Officer (Chief People Officer) | Shares withheld for taxes / exercise cost | 459 | $86.80 | $39.8K | Form 4 |
| 2026-09-12 | SUTULA STANLEY J III | Officer (Chief Financial Officer) | Shares withheld for taxes / exercise cost | 927 | $86.80 | $80.5K | Form 4 |
| 2026-09-12 | Tsourapas Panagiotis | Officer (COO, CD, EMEA, APac, Skin) | Shares withheld for taxes / exercise cost | 618 | $86.80 | $53.6K | Form 4 |
| 2026-09-12 | Wallace Noel R. | Director, Officer (Chairman, President & CEO) | Shares withheld for taxes / exercise cost | 3,516 | $86.80 | $305.2K | Form 4 |
| 2026-09-11 | Fishbone Betsy | Officer (CLO and Secretary) | Shares withheld for taxes / exercise cost | 404 | $86.80 | $35.1K | Form 4 |
| 2026-09-11 | GRANT SHANE | Officer (COO, Americas) | Shares withheld for taxes / exercise cost | 622 | $86.80 | $54.0K | Form 4 |
| 2026-09-11 | Hazlin John | Officer (Chief Growth Officer) | Shares withheld for taxes / exercise cost | 649 | $86.80 | $56.3K | Form 4 |
| 2026-09-11 | Malcolm Gregory | Officer (EVP and Controller) | Shares withheld for taxes / exercise cost | 167 | $86.80 | $14.5K | Form 4 |
| 2026-09-11 | Massey Sally | Officer (Chief People Officer) | Shares withheld for taxes / exercise cost | 651 | $86.80 | $56.5K | Form 4 |
| 2026-09-11 | SUTULA STANLEY J III | Officer (Chief Financial Officer) | Shares withheld for taxes / exercise cost | 1,197 | $86.80 | $103.9K | Form 4 |
| 2026-09-11 | Tsourapas Panagiotis | Officer (COO, CD, EMEA, APac, Skin) | Shares withheld for taxes / exercise cost | 684 | $86.80 | $59.4K | Form 4 |
| 2026-09-11 | Wallace Noel R. | Director, Officer (Chairman, President & CEO) | Shares withheld for taxes / exercise cost | 4,071 | $86.80 | $353.4K | Form 4 |
| 2026-08-24 | Tsourapas Panagiotis | Officer (COO, CD, EMEA, APac, Skin) | Open-market sale | 10,000 | $92.05 | $920.5K | Form 4 |
| 2026-08-06 | CAHILL JOHN T | Director | Option exercise / conversion (derivative) | 4,170 | — | $0 | Form 4 |
| 2026-08-06 | CAHILL JOHN T | Director | Open-market sale | 4,170 | $93.37 | $389.4K | Form 4 |
| 2026-08-06 | CAHILL JOHN T | Director | Option exercise / conversion | 4,170 | $71.56 | $298.4K | Form 4 |
| 2026-08-05 | Wallace Noel R. | Director, Officer (Chairman, President & CEO) | Option exercise / conversion (derivative) | 161,021 | — | $0 | Form 4 |
| 2026-08-05 | Wallace Noel R. | Director, Officer (Chairman, President & CEO) | Open-market sale | 161,021 | $92.52 | $14.90M | Form 4 |
| 2026-08-05 | Wallace Noel R. | Director, Officer (Chairman, President & CEO) | Option exercise / conversion | 161,021 | $72.29 | $11.64M | Form 4 |
| 2026-08-04 | Wallace Noel R. | Director, Officer (Chairman, President & CEO) | Option exercise / conversion (derivative) | 161,021 | — | $0 | Form 4 |
| 2026-08-04 | Wallace Noel R. | Director, Officer (Chairman, President & CEO) | Open-market sale | 161,021 | $91.92 | $14.80M | Form 4 |
| 2026-08-04 | Wallace Noel R. | Director, Officer (Chairman, President & CEO) | Option exercise / conversion | 161,021 | $72.29 | $11.64M | Form 4 |
| 2026-07-01 | BILBREY JOHN P | Director | Grant / award / vesting | 265 | $89.45 | $23.7K | Form 4 |
| 2026-07-01 | Newman Brian | Director | Grant / award / vesting | 209 | $89.45 | $18.7K | Form 4 |
| 2026-07-01 | NORRINGTON LORRIE M | Director | Grant / award / vesting | 293 | $89.45 | $26.2K | Form 4 |
| 2026-06-16 | GRANT SHANE | Officer (COO, Americas) | Shares withheld for taxes / exercise cost | 23,347 | $90.66 | $2.12M | Form 4 |
| 2026-05-15 | Malcolm Gregory | Officer (EVP and Controller) | Open-market sale | 2,300 | $88.44 | $203.4K | Form 4 |
| 2026-05-11 | BILBREY JOHN P | Director | Grant / award / vesting (derivative) | 2,424 | — | $0 | Form 4 |
| 2026-05-11 | BILBREY JOHN P | Director | Grant / award / vesting | 2,075 | — | $0 | Form 4 |
| 2026-05-11 | BOERNER CHRISTOPHER S. | Director | Grant / award / vesting (derivative) | 2,020 | — | $0 | Form 4 |
| 2026-05-11 | BOERNER CHRISTOPHER S. | Director | Grant / award / vesting | 1,383 | — | $0 | Form 4 |
| 2026-05-11 | CAHILL JOHN T | Director | Grant / award / vesting (derivative) | 2,424 | — | $0 | Form 4 |
| 2026-05-11 | CAHILL JOHN T | Director | Grant / award / vesting | 2,075 | — | $0 | Form 4 |
| 2026-05-11 | Edwards Lisa | Director | Grant / award / vesting (derivative) | 2,424 | — | $0 | Form 4 |
| 2026-05-11 | Edwards Lisa | Director | Grant / award / vesting | 2,075 | — | $0 | Form 4 |
| 2026-05-11 | HARRIS C MARTIN | Director | Grant / award / vesting (derivative) | 2,424 | — | $0 | Form 4 |
| 2026-05-11 | HARRIS C MARTIN | Director | Grant / award / vesting | 1,556 | — | $0 | Form 4 |
| 2026-05-11 | NORRINGTON LORRIE M | Director | Grant / award / vesting (derivative) | 2,424 | — | $0 | Form 4 |
| 2026-05-11 | NORRINGTON LORRIE M | Director | Grant / award / vesting | 2,075 | — | $0 | Form 4 |
| 2026-05-11 | HUNDMEJEAN MARTINA | Director | Grant / award / vesting (derivative) | 2,424 | — | $0 | Form 4 |
| 2026-05-11 | HUNDMEJEAN MARTINA | Director | Grant / award / vesting | 2,075 | — | $0 | Form 4 |
| 2026-05-11 | Nelson Kimberly A | Director | Grant / award / vesting (derivative) | 2,424 | — | $0 | Form 4 |
| 2026-05-11 | Nelson Kimberly A | Director | Grant / award / vesting | 2,075 | — | $0 | Form 4 |
| 2026-05-11 | Newman Brian | Director | Grant / award / vesting (derivative) | 2,424 | — | $0 | Form 4 |
| 2026-05-11 | Newman Brian | Director | Grant / award / vesting | 2,075 | — | $0 | Form 4 |
| 2026-05-07 | Massey Sally | Officer (Chief People Officer) | Open-market sale | 8,599 | $87.41 | $751.6K | Form 4 |
Ask the chat about CL's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Colgate-Palmolive (CL).
Last updated 2026-10-01 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.